Tzu Chi Medical Journal
Volume 20, Issue 2 , Pages 91-100 , June 2008

Risk Factors and Genetic Markers of Human Papillomavirus-induced Cervical Carcinogenesis: A Focus on Chinese Populations in Southeast Asia and Southern China

  • Tang-Yuan Chu

      Affiliations

    • Department of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Graduate Institute of Clinical Medicine, Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynecology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Received 11 September 2007 ,Revised 23 October 2007 ,Accepted 16 November 2007.

References 

  1. Chu JY , Huang W , Kuang SQ , et al.   Genetic relationship of populations in China . Proc Natl Acad Sci U S A . 1998;95:11763–11768
  2. Wen B , Li H , Lu D , et al.   Genetic evidence supports demic diffusion of Han culture . Nature . 2004;431:302–305
  3. Chan SY , Ho L , Ong CK , et al.   Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind . J Virol . 1992;66:2057–2066
  4. Ho L , Chan SY , Burk RD , et al.   The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations . J Virol . 1993;67:6413–6423
  5. Ong CK , Chan SY , Campo MS , et al.   Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups . J Virol . 1993;67:6424–6431
  6. Calleja-Macias IE , Villa LL , Prado JC , et al.   Worldwide genomic diversity of the highrisk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16 . J Virol . 2005;79:13630–13640
  7. Liaw KL , Hsing AW , Chen CJ , et al.   Human papillomavirus and cervical neoplasia: a casecontrol study in Taiwan . Int J Cancer . 1995;62:565–571
  8. Li LK , Dai M , Clifford GM , et al.   Human papillomavirus infection in Shenyang City, People's Republic of China: a populationbased study . Br J Cancer . 2006;95:1593–1597
  9. Dai M , Bao YP , Li N , et al.   Human papillomavirus infection in Shanxi Province, People's Republic of China: a populationbased study . Br J Cancer . 2006;95:96–101
  10. Wu RF , Dai M , Qiao YL , et al.   Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation . Int J Cancer . 2007;121:1306–1311
  11. Lin H , Ma YY , Moh JS , Ou YC , Shen SY , ChangChien CC . High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan . Gynecol Oncol . 2006;101:40–45
  12. Lo KW , Wong YF , Chan MK , et al.   Prevalence of human papillomavirus in cervical cancer: a multicenter study in China . Int J Cancer . 2002;100:327–331
  13. Lai CH , Huang HJ , Hsueh S , et al.   Human papillomavirus genotype in cervical cancer: a populationbased study . Int J Cancer . 2007;120:1999–2006
  14. Smith JS , Lindsay L , Hoots B , et al.   Human papillomavirus type distribution in invasive cervical cancer and highgrade cervical lesions: a metaanalysis update . Int J Cancer . 2007;121:621–632
  15. Ding DC, Hsu HC, Huang RL, et al. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: an indication of viral oncogenic potential. Eur J Obstet Gynecol Reprod Biol 2008; in press.
  16. Bao YP , Li N , Smith JS , Qiao YL . Human papillomavirus type distribution in women from Asia: a meta-analysis . Int J Gynecol Cancer . 2008;18:71–79
  17. Lai HC , Sun CA , Yu MH , Chen HJ , Liu HS , Chu TY . Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types . Int J Cancer . 1999;84:553–557
  18. Liaw KL , Hsing AW , Schiffman MH , et al.   Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women . Int J Cancer . 1997;73:775–776
  19. Chan PK , Li WH , Chan MY , Ma WL , Cheung JL , Cheng AF . High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions . J Med Virol . 1999;59:232–238
  20. Huang S , Afonina I , Miller BA , Beckmann AM . Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women . Int J Cancer . 1997;70:408–411
  21. Lin QQ , Yu SZ , Qu W , Cruz Y , Burk RD . Human papillomavirus types 52 and 58 . Int J Cancer . 1998;75:484–485
  22. Munoz N , Bosch FX , de Sanjose S , et al.   Epidemiologic classification of human papillomavirus types associated with cervical cancer . N Engl J Med . 2003;348:518–527
  23. Plummer M , Herrero R , Franceschi S , et al.   Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study . Cancer Causes Control . 2003;14:805–814
  24. Moreno V , Bosch FX , Munoz N , et al.   Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric casecontrol study . Lancet . 2002;359:1085–1092
  25. Munoz N , Franceschi S , Bosetti C , et al.   Role of parity and human papillomavirus in cervical cancer: the IARC multicentric casecontrol study . Lancet . 2002;359:1093–1101
  26. Smith JS , Herrero R , Bosetti C , et al.   Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer . J Natl Cancer Inst . 2002;94:1604–1613
  27. Smith JS , Bosetti C , Munoz N , et al.   Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric casecontrol study . Int J Cancer . 2004;111:431–439
  28. Chan PK , Chang AR , Cheung JL , et al.   Determinants of cervical human papillomavirus infection: differences between highand lowoncogenic risk types . J Infect Dis . 2002;185:28–35
  29. Chen CA , Liu CY , Chou HH , et al.   The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group study . Int J Gynecol Cancer . 2006;16:1801–1808
  30. Sun CA , Liu JF , Wu DM , Nieh S , Yu CP , Chu TY . Viral load of highrisk human papillomavirus in cervical squamous intraepithelial lesions . Int J Gynaecol Obstet . 2002;76:41–47
  31. Sun CA , Lai HC , Chang CC , Neih S , Yu CP , Chu TY . The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix . Gynecol Oncol . 2001;83:95–99
  32. Takami Y , Kondoh G , Saito J , et al.   Cloning and characterization of human papillomavirus type 52 from cervical carcinoma in Indonesia . Int J Cancer . 1991;48:516–522
  33. Ho CM , Chien TY , Huang SH , Lee BH , Chang SF . Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer . Gynecol Oncol . 2006;102:54–60
  34. Clifford GM , Rana RK , Franceschi S , Smith JS , Gough G , Pimenta JM . Human papillomavirus genotype distribution in lowgrade cervical lesions: comparison by geographic region and with cervical cancer . Cancer Epidemiol Biomarkers Prev . 2005;14:1157–1164
  35. Chan PK , Lam CW , Cheung TH , et al.   Association of human papillomavirus type 58 variant with the risk of cervical cancer . J Natl Cancer Inst . 2002;94:1249–1253
  36. Lai HC , Peng MY , Nieh S , et al.   Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis . Int J Gynecol Cancer . 2006;16:730–735
  37. Sun CA , Hsiung CA , Lai CH , et al.   Epidemiologic correlates of cervical human papillomavirus prevalence in wo men with abnormal Pap smear tests: a Taiwan Cooperative Oncology Group (TCOG) study . J Med Virol . 2005;77:273–281
  38. Cuzick J , De Stavola B , McCance D , et al.   A casecontrol study of cervix cancer in Singapore . Br J Cancer . 1989;60:238–243
  39. Wang PD , Lin RS . Risk factors for cervical intraepithelial neoplasia in Taiwan . Gynecol Oncol . 1996;62:10–18
  40. Naucler P , Chen HC , Persson K , et al.   Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested casecontrol study . J Gen Virol . 2007;88:814–822
  41. Chou P , Lai MY , Chang HJ . Epidemiology of cervical cancer in the screened population in Taiwan, 1979-1984 . Zhonghua Yi Xue Za Zhi (Taipei) . 1990;45:209–221
  42. Critchlow CW , Wolner-Hanssen P , Eschenbach DA , et al.   Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching . Am J Obstet Gynecol . 1995;173:534–543
  43. Onderdonk AB , Delaney ML , Hinkson PL , DuBois AM . Quantitative and qualitative effects of douche preparations on vaginal microflora . Obstet Gynecol . 1992;80:333–338
  44. Naucler P , Chen HC , Persson K , et al.   Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested casecontrol study . J Gen Virol . 2007;88:814–822
  45. Magnusson PK , Sparen P , Gyllensten UB . Genetic link to cervical tumours . Nature . 1999;400:29–30
  46. Lai HC , Sytwu HK , Sun CA , et al.   Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis . Int J Cancer . 2003;103:221–225
  47. Lai HC , Lin WY , Lin YW , et al.   Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: an analysis of haplotype and genegene interaction . Gynecol Oncol . 2005;99:113–118
  48. Lai HC , Chang CC , Lin YW , et al.   Genetic polymorphism of the interferongamma gene in cervical carcinogenesis . Int J Cancer . 2005;113:712–718
  49. Lai HC , Chu CM , Lin YW , et al.   Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer . Gynecol Oncol . 2005;96:314–319
  50. Huang YK , Hsieh HC , Sun JA , et al.   Genetic polymorphisms of phase I and phase II xenobiotic enzymes in human papillomavirus related lesion and cancer of the uterine cervix . Tzu Chi Med J . 2006;18:267–274
  51. Chan DP , Cheung TH , Tam AO , et al.   Risk association between human leukocyte antigen-A allele and highrisk human papillomavirus infection for cervical neoplasia in Chinese women . J Infect Dis . 2005;192:1749–1756
  52. Chan PK , Cheung JL , Cheung TH , et al.   HLA-DQB1 polymorphisms and risk for cervical cancer: a casecontrol study in a southern Chinese population . Gynecol Oncol . 2007;105:736–741
  53. Chan PK , Cheung TH , Lin CK , et al.   Association between HLA-DRB1 polymorphism, highrisk HPV infection and cervical neoplasia in southern Chinese . J Med Virol . 2007;79:970–976
  54. Chen CA , Chen TM , Wu CC , Chang CF , Hsieh CY . Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer . J Cancer Res Clin Oncol . 1994;120:678–682
  55. Pao CC , Kao SM , Chen JH , Tang GC , Chang PY , Tan TT . State of mutational alterations of p53 and retinoblastoma susceptibility genes in papillomavirusnegative small cell cervical carcinomas . J Surg Oncol . 1994;57:87–93
  56. Ngan HY , Liu VW , Liu SS . Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53 . Br J Cancer . 1999;80:1828–1829
  57. Chu TY , Shen CY , Chiou YS , et al.   HPV-associated cervical cancers show frequent allelic loss at 3p14 but no ap parent aberration of FHIT mRNA . Int J Cancer . 1998;75:199–204
  58. Chu TY , Lai JS , Shen CY , Liu HS , Chao CF . Frequent aberration of the transforming growth factorbeta receptor II gene in cell lines but no apparent mutation in preinvasive and invasive carcinomas of the uterine cervix . Int J Cancer . 1999;80:506–510
  59. Chang JG , Su TH , Wei HJ , et al.   Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers . Br J Cancer . 1999;79:445–450
  60. Cheung TH , Yu MM , Lo KW , Yim SF , Chung TK , Wong YF . Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix . Cancer Lett . 2001;166:199–206
  61. Su TH , Chang JG , Perng LI , et al.   Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer . Gynecol Oncol . 2000;76:193–199
  62. Ku WH , Liu IL , Yen MS , et al.   Genomic deletion and p53 inactivation in cervical carcinoma . Int J Cancer . 1997;72:270–276
  63. Chang CL , Wang SY , Wu CC , et al.   Microsatellite alterations in exfoliated cervical epithelia deoxyribonucleic acid as a marker for highgrade dysplasia . Am J Obstet Gynecol . 2001;185:108–115
  64. Chung GT , Huang DP , Lo KW , Chan MK , Wong FW . Genetic lesion in the carcinogenesis of cervical cancer . Anticancer Res . 1992;12:1485–1490
  65. Wong YF , Chung TK , Cheung TH , Tam PO , Chang AM . Frequent loss of heterozygosity of chromosome 3 short arm de tected by PCR-based microsatellite polymorphisms in cervical squamous cell carcinoma . Cancer Lett . 1997;115:161–164
  66. Chung TK , Cheung TH , Lo WK , et al.   Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia . Cancer Lett . 2000;154:189–194
  67. Cheung TH , Lo KW , Yim SF , et al.   Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer . Gynecol Oncol . 2005;96:510–515
  68. Cheung TH , Chung TK , Poon CS , Hampton GM , Wang VW , Wong YF . Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma . Cancer . 1999;86:1294–1298
  69. Wong YF , Chung TK , Cheung TH , et al.   Methylation of p16INK4A in primary gynecologic malignancy . Cancer Lett . 1999;136:231–235
  70. Yu MY , Tong JH , Chan PK , et al.   Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers . Int J Cancer . 2003;105:204–209
  71. Lai HC , Lin YW , Chang CC , et al.   Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias . Gynecol Oncol . 2007;104:629–635
  72. Cheung TH , Lo KW , Yim SF , et al.   Epigenetic and genetic alternation of PTEN in cervical neoplasm . Gynecol Oncol . 2004;93:621–627
  73. Liu SS , Leung RC , Chan KY , et al.   p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy . Clin Cancer Res . 2004;10:3309–3316
  74. Yang HJ , Liu VW , Wang Y , et al.   Detection of hypermethylated genes in tumor and plasma of cervical cancer patients . Gynecol Oncol . 2004;93:435–440
  75. Seng TJ , Low JS , Li H , et al.   The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation . Oncogene . 2007;26:934
  76. Chu TY , Shen CY , Lee HS , Liu HS . Monoclonality and surface lesionspecific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution . Genes Chromosomes Cancer . 1999;24:127–134
  77. Badal V , Chuang LS , Tan EH , et al.   CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression . J Virol . 2003;77:6227–6234
  78. Jones PA , Baylin SB . The fundamental role of epigenetic events in cancer . Nat Rev Genet . 2002;3:415–428
  79. Larsen F , Gundersen G , Lopez R , Prydz H . CpG islands as gene markers in the human genome . Genomics . 1992;13:1095–1107
  80. Widschwendter A , Gattringer C , Ivarsson L , et al.   Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors . Clin Cancer Res . 2004;10:3396–3400
  81. Feng Q , Balasubramanian A , Hawes SE , et al.   Detection of hypermethylated genes in women with and without cervical neoplasia . J Natl Cancer Inst . 2005;97:273–282
  82. Sano T , Oyama T , Kashiwabara K , Fukuda T , Nakajima T . Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions . Am J Pathol . 1998;153:1741–1748
  83. Klaes R , Friedrich T , Spitkovsky D , et al.   Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri . Int J Cancer . 2001;92:276–284
  84. Chen SF , Yang SF , Chu TY , et al.   Which test is a better strategy to determine the outcome of atypical glandular cellcategorized Pap smears? Immunocytochemical p16(INK4A) expression or human papillomavirus testa retrospective cohort study . Gynecol Oncol . 2005;99:578–584
  85. Nieh S , Chen SF , Chu TY , Lai HC , Fu E . Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix . Gynecol Oncol . 2003;91:201–208
  86. Nieh S , Chen SF , Chu TY , et al.   Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significancecategorized Pap smear? A comparative analysis using abnormal cervical smears with followup biopsies . Gynecol Oncol . 2005;97:35–40
  87. Pao CC , Tseng CJ , Lin CY , et al.   Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions . J Clin Oncol . 1997;15:1932–1937
  88. Wang PH , Ko JL . Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence . Int J Gynecol Cancer . 2006;16:1873–1879
  89. Zhang DK , Ngan HY , Cheng RY , Cheung AN , Liu SS , Tsao SW . Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer . Eur J Cancer . 1999;35:154–160
  90. Cheung AN , Chiu PM , Tsun KL , Khoo US , Leung BS , Ngan HY . Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology . J Clin Pathol . 2004;57:721–727

PII: S1016-3190(08)60017-8

doi: 10.1016/S1016-3190(08)60017-8

Tzu Chi Medical Journal
Volume 20, Issue 2 , Pages 91-100 , June 2008

Article Tools